An honest conversation about what it takes to turn a scientific breakthrough into a growing company. Following the launch of Innovation Forum Glasgow, Founders Unfiltered returns for a second discussion with founders, researchers and innovation leaders from across Scotland’s science and technology ecosystem. This session moves beyond the initial idea to explore the messy middleaaa

“It’s your job to figure out if it’s a problem you’re solving, or if it’s a problem you’re making up”  Shyam Srinivasan completed his undergraduate studies in medical engineering at VIT University in India and a master’s degree in biomedical computing at the Technical University of Munich. He made the jump from research to  entrepreneurship when heaaa

As an entrepreneur, you have to align so many different processes to realize your vision: from funding, to research and development, then patenting and licensing, and finally production and advertising. For each of these processes, you have to describe to those involved − precisely and convincingly − what your product is and how it willaaa

Narges Sheikhansari: Thanks for accepting our invitation to this interview. It’s great to have you here today. So, the first question is about your team. What are your backgrounds and what is your founding story?  Isaac Johnson: That’s a really great place to start. I think for us, it all started back, in 2019. So, back thenaaa

Narges Sheikhansari: Tell us about your team. What are your backgrounds and what is your founding story? Tanay Bhatt: At this stage of pre-expansion, we have a small team consisting of Professor Colin Jamora, Ms. Shreyaa, and myself. I did my PhD under Prof. Colin’s guidance, on the topics of wound-healing, antimicrobial resistance (AMR), and skin associatedaaa

There is no doubt that the current pandemic is challenging individuals and communities worldwide with unforeseen problems, whether they are directly related to people’s health or not. As history tells us, when humans face a common enemy, the solidarity and sense of belonging to a single race are unbelievable. We are putting aside our differences,aaa

This month, Sabyasachi Dash of IFNY sat down with Fran Strauss, Principal at HealthMark Strategies in New York City. Fran is a proven Reimbursement & Payer Commercialization Strategist and Market Access Executive with expertise in genetic testing, molecular diagnostics, medical/mobile devices, personalized medicine and diagnostic laboratories. She works with commercial and government payers, employers, unions andaaa

Lifebit CloudOS Gains Increased Market Adoption, Drives Groundbreaking Research in Life Sciences LONDON, UK – April 30, 2020 – Lifebit Biotech, a leading innovator in bioinformatics and cognitive software solutions, today announced it closed its Series A funding round of US $7.5M (£6 million GBP) led by Idinvest Partners, to fuel ongoing product innovations andaaa

Lately, the Innovation Forum (IF) Manchester held another successful workshop, dedicated to leadership skills development for postgraduate students, recent graduates and young professionals.  Here one of the workshop leaders, Anastassia Bolotkova, shares her personal reflections. Amidst discussions on leadership development, the perspectives of Christian business expert Kurt Uhlir offer a unique blend of spiritual wisdomaaa

Brexit has watermarked Britain’s future and has thrown not only the country but the whole scientific community into an enigma with a desperate need to stabilize its critical condition.  This may affect Britain tapping into shared science and funding as well as discouraging scientific talents globally.  What becomes of access to EU funding for manyaaa